Tesla Optimus Is Already Benefiting Investors, Top Wall Street Firm Says

Key Takeaways

• Piper Sandler values core Tesla at $400/share, excludes Optimus.
• Optimus considered “free” at current $400‑$420 price range.
• Overweight rating and $500 target imply $100 robot premium.
• Analyst forecasts lower 2026‑27 deliveries but emphasizes FSD growth.
• Long‑term robot and inference services could outvalue existing businesses.

Pulse Analysis

Piper Sandler’s latest valuation of Tesla separates the company’s established revenue streams—from electric vehicles and energy storage to Full Self‑Driving software and a nascent robotaxi operation—from the still‑emerging Optimus humanoid robot. By assigning roughly $400 per share to these core assets and leaving Optimus unpriced, the firm argues that current market prices of $400‑$420 effectively give shareholders the robot at no additional cost. This granular approach, detailed in the “Definitive Guide to Investing in Tesla,” underpins an Overweight recommendation and a $500 price target, implicitly valuing robot‑related opportunities at about $100 per share.

The implication for investors is twofold. First, the market is already pricing in a substantial portion of Tesla’s future AI and robotics potential, meaning exposure to Optimus does not require a premium today. Second, if Optimus and associated inference‑as‑a‑service offerings eventually surpass the revenue of Tesla’s traditional businesses, the upside could be material, reshaping the company’s growth story beyond automotive and energy. This perspective aligns with a broader industry trend where Wall Street analysts increasingly factor in high‑growth, speculative technologies—such as autonomous robotaxis and AI‑driven services—into enterprise valuations.

However, the optimism carries notable risks. Optimus remains in early development, with commercial deployment still years away, and the timeline for scaling inference services is uncertain. Piper Sandler’s model also projects lower vehicle deliveries for 2026‑27, reflecting potential headwinds from discontinued models and diminishing regulatory credit income. Investors must weigh these execution uncertainties against the tantalizing long‑term upside, recognizing that divergent analyst views on how to monetize emerging robotics platforms could lead to significant valuation swings in the months ahead.